EGFR and non-small cell lung carcinoma: Additionally, Kanaji et al., in 218 patients with NSCLC, reported that while patients with IPF (n = 34) had no EGFR mutation, 32% of patients with non-interstitial lung disease (ILD) (n = 165) had EGFR mutation39.